News Quantified

NVO – novo nordisk a/s (US:NASDAQ)

Stock Stats

News Stats

Order Stats

News

FDA approves Alhemo® injection as once-daily prophylactic treatment to prevent or reduce the frequency of bleeding episodes for adults and children 12 years of age and older with hemophilia A or B with inhibitors [Yahoo! Finance]

Eli Lilly's obesity drug Zepbound gains approval to treat sleep apnea [USA TODAY]

Why Viking Therapeutics Tumbled by More Than 10% This Week [Yahoo! Finance]

Stock market today: Dow, S&P 500, Nasdaq rebound on fresh inflation data to cap volatile week [Yahoo! Finance Canada]

Yahoo Finance [Yahoo! Finance]

-0.2%

BEAT

2.0%

BEAT

-7.3%

BEAT

4.3%

BEAT

Cantor Fitzgerald

Cantor Fitzgerald

Form 6-K NOVO NORDISK A S For: Dec 20

Form 6-K NOVO NORDISK A S For: Dec 20

Form 6-K NOVO NORDISK A S For: Dec 18

Form 6-K NOVO NORDISK A S For: Dec 16

Form 6-K NOVO NORDISK A S For: Dec 14

Top News Gainers

3/17 Form 6-K NOVO NORDISK A S For: Mar 16 6.0%

3/16 Novo Nordisk A/S (NYSE: NVO) was upgraded by analysts at Bank of America Corp from a "neutral" rating to a "buy" rating. 4.7%

2/5 Q4/2019 12/31/2019 EPS 3.700 ZacksConsensus 0.550 ActVsEst 3.150 - Beat 4.6%

6/8 Novo's oral semaglutide successful in two late-stage T2D studies [Seeking Alpha] 3.8%

11/8 Novo Nordisk: Actual Numbers Not As Good As Headlines But Still Quite Solid [Seeking Alpha] 3.2%

3/27 Form 6-K NOVO NORDISK A S For: Mar 26 3.2%

8/12 Q2/2019 6/30/2019 EPS 4.030 ZacksConsensus 0.610 ActVsEst 3.420 - Beat 3.0%

9/17 With a backup to the backup, insulin makers say they're primed for Brexit [Reuters (UK)] 3.0%

11/1 Form 6-K NOVO NORDISK A S For: Nov 01 2.7%

8/8 Europe stocks climb in early action, led by pharmas [MarketWatch] 2.4%

Top News Decliners

9/9 Form 6-K NOVO NORDISK A S For: Sep 09 -3.6%

11/20 Form 6-K NOVO NORDISK A S For: Nov 20 -2.8%

12/18 Form 6-K NOVO NORDISK A S For: Dec 16 -2.5%

3/9 Form 6-K NOVO NORDISK A S For: Mar 09 -2.4%

4/7 Team Novo Nordisk and Beyond Type 1 Announce New Partnership -2.4%

1/3 Novo Nordisk: A Rare Case of Pharma With Balanced Risk and Reward [Yahoo! Finance News] -2.2%

4/28 Form 6-K NOVO NORDISK A S For: Apr 27 -2.1%

9/10 Novo Nordisk A/S (NYSE: NVO) was downgraded by analysts at ValuEngine from a "hold" rating to a "sell" rating. -2.1%

3/23 Form 6-K NOVO NORDISK A S For: Mar 23 -1.8%

10/1 Form 6-K NOVO NORDISK A S For: Sep 30 -1.6%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

Latest Posts

Trading the Google Earnings Announcement: A Strategic Preview

Earnings Week Wrap-up and Takeaways

Earnings Season: Q3 Review, Q4 Kickoff – Morgan Stanley, Bank of America, Goldman Sachs, Netflix

Guerrilla Learning Opportunity: Wealth365 Conference Featuring News Quantified Founder and Much More

The Smart Way to Ten Minutes Per Day